Cargando…
Erlotinib-induced purpuric papulopustular eruption treated with pulsed azithromycin
Erlotinib belongs to the targeted cancer treatments acting through epidermal growth factor receptor inhibition. Papulopustular eruption is the most common cutaneous toxicity. The pathogenesis of the rash is not clear. There is no consensus on treatment. In this report, we describe a 73-year-old fema...
Autores principales: | Akoglu, Gulsen, Yavuz, Sibel Orhun, Metin, Ahmet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900010/ https://www.ncbi.nlm.nih.gov/pubmed/27298507 http://dx.doi.org/10.4103/0253-7613.182887 |
Ejemplares similares
-
Azithromycin induced bullous fixed drug eruption
por: Das, Anupam, et al.
Publicado: (2016) -
Docetaxel-induced palmoplantar erythrodysesthesia syndrome and long-lasting multiple nail changes
por: Akoglu, Gulsen
Publicado: (2014) -
Acemetacin-induced fixed drug eruption
por: Cebeci, Filiz, et al.
Publicado: (2016) -
Nicolau syndrome following subcutaneous glatiramer acetate injection: A case report and review of the literature
por: Esme, Pelin, et al.
Publicado: (2021) -
Terbinafine induced pityriasis rosea-like eruption
por: George, Anisha, et al.
Publicado: (2015)